Get the Stockscreener App
2.29
0.00%
0.00
Femasys Inc stock is traded at $2.29, with a volume of 116.28K.
It is up +0.00% in the last 24 hours and down -36.39% over the past month.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
See More
Previous Close:
$2.29
Open:
$2.33
24h Volume:
116.28K
Relative Volume:
1.24
Market Cap:
$6.91M
Revenue:
$2.38M
Net Income/Loss:
$-12.40M
P/E Ratio:
-0.3543
EPS:
-6.4626
Net Cash Flow:
$-18.68M
1W Performance:
-13.91%
1M Performance:
-36.39%
6M Performance:
-77.47%
1Y Performance:
-84.58%
1-Day Range:
$2.26
$2.3799
1-Week Range:
$2.19
$2.8728
52-Week Range:
$2.19
$22.20
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys Inc
Sector
Industry
Phone
770-500-3910
Address
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
2.29 | 7.10M | 2.38M | -12.40M | -18.68M | -6.4626 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-25 | Initiated | Laidlaw | Buy |
Femasys Inc Stock (FEMY) Latest News
Femasys Q2 EPS $(1.08) beats estimate; sales rise 85% - scanx.trade
Femasys (NASDAQ: FEMY) cuts net loss and secures $30M private funding - Stock Titan
Femasys Reports $331,827 Q2 Revenue and $4.47 Million Net Loss - Quiver Quantitative
Femasys Inc. (NASDAQ: FEMY) narrows first-half loss, completes $30M financing - Stock Titan
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update - GlobeNewswire
Maxim Group Maintains Femasys(FEMY.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Femasys (FEMY) gains Rosalind-linked holder with potential 9.99% equity stake - Stock Titan
Femasys Strengthens and Extends Global Patent Protection for FemBloc with First Issued Blended Polymer Patents - marketscreener.com
Femasys receives patents for FemBloc birth control polymer - Investing.com
Femasys receives patents for FemBloc birth control polymer By Investing.com - Investing.com UK
Femasys Secures New U.S. and International Patents for FemBloc Blended Polymer, Expanding Global IP Protection - Quiver Quantitative
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents - Yahoo Finance
Femasys COO John Canning buys $14,000 in FEMY stock By Investing.com - Investing.com South Africa
Femasys CFO Dov Elefant buys $50,000 in company stock By Investing.com - Investing.com South Africa
Femasys chief clinical-medical affairs Mifek buys $10,000 stock - Investing.com
Femasys CTO Jeremy Sipos buys $10,000 in common stock By Investing.com - Investing.com South Africa
Femasys CEO Kathy Lee-Sepsick buys $50,000 in FEMY stock By Investing.com - Investing.com South Africa
Femasys CTO Jeremy Sipos buys $10,000 in common stock - Investing.com
Femasys CEO Kathy Lee-Sepsick buys $50,000 in FEMY stock - Investing.com
Form 8K Femasys Inc For: 11 August By Investing.com - Investing.com South Africa
Femasys completes $30 million private placement financing - TipRanks
Femasys Raises $30 Million in Private Placement; Adds Investor Board Rights, Ends Prior Nomination Rights - TradingView
Femasys (FEMY) secures $30M private placement with extensive warrant package and board rights - Stock Titan
Femasys Inc expected to post a loss of $1.30 a shareEarnings Preview - TradingView
Enterprise value to EBITDA forward of Femasys Inc. – NASDAQ:FEMY - TradingView
Enterprise value to revenue forward of Femasys Inc. – NASDAQ:FEMY - tradingview.com
Femasys raises $30M in private placement with p... - Pluang
Femasys secures $30 million private placement financing By Investing.com - Investing.com India
Femasys Inc (FEMY) Stock News Today - TradingKey
Femasys prices USD 30 million private placement at USD 3.2 per share - Bitget
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million - The Manila Times
Femasys Inc. Announces $30 Million Private Placement Led by Nantahala Capital With Up to $60 Million in Potential Warrant Proceeds - Quiver Quantitative
Femasys Could Receive Up to $60M If Warrants Are Exercised - Stock Titan
Femasys Inc (FEMY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Femasys Inc. announced that it expects to receive $29.999561 million in funding from Rosalind Advisors, Inc., Nantahala Capital Management, LLC - marketscreener.com
FEMY Q2'26 Earnings: revenue estimate is 730.67K USD - TradingView
Femasys Inc (NASDAQ: FEMY) Share Price, FEMY Stock News, FEMY Share Price & Updates - Kalkine
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Beat on Narrower Loss, Stock SlipsAnalyst Earnings Estimate - dars.gov.et
Femasys Inc (FEMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Femasys Inc (FEMY) Dividends & Stock Splits: Historical Payouts and Event Timeline - tradingkey.com
Femasys Inc (FEMY) Cash Flow - TradingKey
Femasys Inc (FEMY) Balance Sheet - TradingKey
Femasys Inc (FEMY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Femasys Inc. (FEMY) Slips 2.1% as Stock Tests Key Support LevelBollinger Squeeze - dars.gov.et
Femasys Inc (FEMY) Income Statement - TradingKey
Femasys Inc (FEMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
FEMY|Femasys Inc|Price:3.060|Chg%:-0.650 - TradingKey
Femasys Inc (FEMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Femasys Company Profile & Introduction - Moomoo
Femasys Inc (FEMY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Surprise Beats Estimates, Stock SurgesDiluted EPS Report - dars.gov.et
Femasys Inc Stock (FEMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):